$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Indications and applicable groups of cimepilimab
2026-02-01 22:25:32
Check Details
How to rationally use daprostat to treat anemia in patients with chronic kidney disease
2026-02-01 22:25:32
Check Details
What is the therapeutic effect of durvalumab and what is the clinical feedback?
2026-02-01 22:25:32
Check Details
How much is the latest market price of zotuximab for injection?
2026-02-01 22:25:32
Check Details
What are the common adverse reactions of margetuximab?
2026-02-01 22:25:32
Check Details
What are the correct ways to eat and what are the precautions for taking ivonib?
2026-02-01 22:25:32
Check Details
How does the price of mitotane compare to other drugs?
2026-02-01 22:25:32
Check Details
How many boxes of pemetinib/pemetinib are needed per month?
2026-02-01 22:25:32
Check Details
Approximately how many boxes of erdafitinib are required per month?
2026-02-01 22:25:32
Check Details
Is erlotinib suitable for all patients with non-small cell lung cancer?
2026-02-01 22:25:32
Check Details
Does tofacitinib's effect on the JAK pathway meet the definition of a targeted drug?
2026-02-01 22:25:32
Check Details
Interpretation of the latest conditions for medical insurance reimbursement of Ribociclib/Ribociclib
2026-02-01 22:25:32
Check Details
1
2
...
1523
1524
1525
1526
1527
1528
1529
...
10212
10213
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Tucatinib (Tukysa): A Precision Medicine for HER2-Positive Breast & Colorectal Cancer
2
Venetoclax Therapy Guidelines: Balancing Precision Targeting with Risk Management
3
Global Breakthrough: Pralsetinib - Precision Medicine for RET Mutation-Driven Cancers
4
A Comprehensive Guide to Benralizumab Adverse Reactions: Prevention and Management
5
Lemborexant: A Dual Orexin Receptor Antagonist Revolutionizing Insomnia Treatment
6
Breztri Aerosphere Approved by US FDA for Maintenance Treatment of Asthma in Patients Aged 12 Years and Older
7
Datopotamab Deruxtecan as First-Line Treatment for Advanced Triple-Negative Breast Cancer: Full Interpretation of the Phase III TROPION-Breast02 Trial
8
Elacestrant: Precision Therapy for ESR1-Mutant Resistant HR+/HER2- Advanced Breast Cancer
9
Vibegron 2026 Research Updates: New Evidence for Overactive Bladder Treatment
10
Elafibranor for Cholestatic Liver Diseases: Efficacy Maintenance and Drug Resistance Analysis
11
Benzgalantamine (Zunveyl) for Alzheimer's Disease: Efficacy and Optimal Treatment Stages
12
Loargys(Pegzilarginase-nbln) Complete Medication Guide: Pre-Treatment Assessment, Monitoring and Home Administration